The Aplastic Anaemia Trust, our Research and Clinical Advisory Panel, and Professor Ted Gordon Smith have published a report into the priorities for research and improving clinical care in rare bone marrow failure. Read more
The last video in our little series: Given all these improvements, what should we be looking forward to in the next 40 years? Professor Gordon Smith and Dr Austin share what they're most excited about. Read more
Prof Gordon Smith asks Dr Austin about what transplants are like for aplastic anaemia patients now, and learns about one huge advance since his day. Read more
We learn about why The AAT started, who started it, and what that had to do with tents. Read more
In this second video celebrating 40 years of The Aplastic Anaemia Trust, Professor Ted Gordon Smith shares what he thinks of ATG! And we learn the name of the first ATG horse... Read more
To celebrate 40 years of The Aplastic Anaemia Trust, we invited Professor Ted Gordon Smith to Kings Hospital to meet with Dr Austin Kulasekararaj and discuss treatment for aplastic anaemia and how it has improved. In this first video, Professor Gordon Smith talks about how clinicians first started using transplant for patients with aplastic anaemia, in the mid 1970s. Read more
King’s College Hospital and King’s College London are trialling cutting-edge cell therapy to develop a brand new treatment for the condition. It’s a world first - funded by The Aplastic Anaemia Trust and LifeArc. On 7th December, Dr Nazia Matto, the trial’s lead GMP production scientist presented initial findings from the TIARA trial, revealing promising results Read more
The Aplastic Anaemia Trust will fund a new research project, investigating genetic mutations in patients with aplastic anaemia or PNH. Read more
Read the new plain language summary of the RACE trial to learn more about how taking eltrombopag alongside treatment with horse ATG and ciclosporin has been shown to lead to faster treatment response for people with severe and very severe aplastic anaemia. Read more
The TIARA trial at King’s College Hospital in London is now recruiting adult patients to trial a brand new potential treatment. Could you help? Find out if you could meet the criteria, and how to take part. Read more
We are very proud to announce that the recent Leeds Covid vaccination study, funded by The Aplastic Anaemia Trust, has been published today in The Lancet Haematology. Read more
The new study will shed light on the question of how effective the Covid-19 vaccines are in aplastic anaemia patients. Read more
On December 6th, The Aplastic Anaemia Trust community received this update from the research team in Leeds about their study into the Covid-19 vaccine and people with aplastic anaemia and PNH. Watch the full presentation here! Read more
Good progress made up until the Covid-19 crisis. Work set to resume once lockdown restrictions have been eased. Read more
Update on a project led by the researchers at King’s College Hospital/King’s College London, funded by the AAT, April 2020 Read more